LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 23

Suchoptionen

  1. Artikel: Impact of Low-Burden

    Lazarian, Gregory / Cymbalista, Florence / Baran-Marszak, Fanny

    Frontiers in oncology

    2022  Band 12, Seite(n) 841630

    Abstract: In chronic lymphocytic leukemia (CLL), ...

    Abstract In chronic lymphocytic leukemia (CLL),
    Sprache Englisch
    Erscheinungsdatum 2022-02-08
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2022.841630
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Post-SARS-CoV-2 vaccination acute hemolysis in an older man: don't forget to look at the blood smear.

    Duchemann, Boris / Lazarian, Gregory

    Blood

    2021  Band 138, Heft 21, Seite(n) 2153

    Mesh-Begriff(e) Aged ; Antibodies, Monoclonal/therapeutic use ; Blood Transfusion ; COVID-19 Vaccines/adverse effects ; Carcinoma, Non-Small-Cell Lung/blood ; Carcinoma, Non-Small-Cell Lung/complications ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Diagnosis, Differential ; Glucosephosphate Dehydrogenase Deficiency/complications ; Hemolysis ; Humans ; Jaundice/etiology ; Lung Neoplasms/blood ; Lung Neoplasms/complications ; Lung Neoplasms/drug therapy ; Male ; Vaccination/adverse effects ; Vicia faba/adverse effects
    Chemische Substanzen Antibodies, Monoclonal ; COVID-19 Vaccines ; durvalumab (28X28X9OKV)
    Sprache Englisch
    Erscheinungsdatum 2021-11-25
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2021013354
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: A rare case of leukemic anaplastic large cell lymphoma with the variant translocation t(X;2).

    Tueur, Giulia / Lazarian, Gregory

    Blood

    2019  Band 134, Heft 17, Seite(n) 1480

    Mesh-Begriff(e) Adult ; Anaplastic Lymphoma Kinase/genetics ; Female ; Humans ; Lymphoma, Large-Cell, Anaplastic/genetics ; Lymphoma, Large-Cell, Anaplastic/pathology ; Microfilament Proteins/genetics ; Oncogene Proteins, Fusion/genetics ; Translocation, Genetic
    Chemische Substanzen Microfilament Proteins ; Oncogene Proteins, Fusion ; moesin (144131-77-1) ; ALK protein, human (EC 2.7.10.1) ; Anaplastic Lymphoma Kinase (EC 2.7.10.1)
    Sprache Englisch
    Erscheinungsdatum 2019-11-04
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2019002519
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.

    Debureaux, Pierre-Edouard / Forgeard, Nathalie / Elessa, Dikelele / Harel, Stéphanie / Frenzel, Laurent / Royer, Bruno / Talbot, Alexis / Choquet, Sylvain / Davi, Frederic / Nguyen-Khac, Florence / Cuccuini, Wendy / Cheminant, Morgane / Bravetti, Clotilde / Lazarian, Gregory / Kaltenbach, Sophie / Hermine, Olivier / Roos-Weil, Damien / Espéli, Marion / Balabanian, Karl /
    Arnulf, Bertrand

    Haematologica

    2024  Band 109, Heft 1, Seite(n) 325–330

    Mesh-Begriff(e) Humans ; Waldenstrom Macroglobulinemia/drug therapy ; Tyrosine Kinase Inhibitors ; Agammaglobulinaemia Tyrosine Kinase ; Inflammation ; Protein Kinase Inhibitors/therapeutic use
    Chemische Substanzen Tyrosine Kinase Inhibitors ; Agammaglobulinaemia Tyrosine Kinase (EC 2.7.10.2) ; Protein Kinase Inhibitors
    Sprache Englisch
    Erscheinungsdatum 2024-01-01
    Erscheinungsland Italy
    Dokumenttyp Journal Article
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.2023.283141
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.

    Lazarian, Gregory / Guièze, Romain / Wu, Catherine J

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2017  Band 35, Heft 9, Seite(n) 984–993

    Abstract: Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy with a remarkably heterogeneous course, ranging from indolent disease with no need for immediate therapy to rapidly progressive disease associated with therapeutic resistance. The recent US ...

    Abstract Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy with a remarkably heterogeneous course, ranging from indolent disease with no need for immediate therapy to rapidly progressive disease associated with therapeutic resistance. The recent US Food and Drug Administration approvals of novel targeted therapies such as inhibitors of B-cell receptor signaling and B-cell lymphoma 2 have opened up new opportunities in the clinical management of patients with CLL and heralded a new era in the clinical treatment of this disease. In parallel, the implementation of novel sequencing technologies has provided new insights into CLL complexity, identifying a growing list of putative drivers that underlie inter- and intratumor heterogeneities in CLL affecting disease progression and resistance. The identification of these novel genomic features that can indicate future drug resistance or guide therapeutic management is now becoming a major goal in CLL so that patients can best benefit from the increasingly diverse available therapies, as discussed herein.
    Mesh-Begriff(e) Genomics/methods ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/therapy
    Sprache Englisch
    Erscheinungsdatum 2017-02-13
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.2016.71.0822
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment.

    Mihoub, Imane / Rharass, Tareck / Ouriemmi, Souhaïl / Oudar, Antonin / Aubard, Laure / Gratio, Valérie / Lazarian, Gregory / Ferreira, Jordan / Dondi, Elisabetta / Cymbalista, Florence / Levy, Vincent / Baran-Marszak, Fanny / Varin-Blank, Nadine / Ledoux, Dominique / Le Roy, Christine / Gardano, Laura

    International journal of molecular sciences

    2023  Band 24, Heft 24

    Abstract: In the microenvironment, cell interactions are established between different cell types to regulate their migration, survival and activation. β-Catenin is a multifunctional protein that stabilizes cell-cell interactions and regulates cell survival ... ...

    Abstract In the microenvironment, cell interactions are established between different cell types to regulate their migration, survival and activation. β-Catenin is a multifunctional protein that stabilizes cell-cell interactions and regulates cell survival through its transcriptional activity. We used chronic lymphocytic leukemia (CLL) cells as a cellular model to study the role of β-catenin in regulating the adhesion of tumor cells to their microenvironment, which is necessary for tumor cell survival and accumulation. When co-cultured with a stromal cell line (HS-5), a fraction of the CLL cells adhere to stromal cells in a dynamic fashion regulated by the different levels of β-catenin expression. In non-adherent cells, β-catenin is stabilized in the cytosol and translocates into the nucleus, increasing the expression of cyclin D1. In adherent cells, the level of cytosolic β-catenin is low but membrane β-catenin helps to stabilize the adhesion of CLL to stromal cells. Indeed, the overexpression of β-catenin enhances the interaction of CLL with HS-5 cells, suggesting that this protein behaves as a regulator of cell adhesion to the stromal component and of the transcriptional regulation of cell survival. Inhibitors that block the stabilization of β-catenin alter this equilibrium and effectively disrupt the support that CLL cells receive from the cross-talk with the stroma.
    Mesh-Begriff(e) Humans ; beta Catenin/genetics ; beta Catenin/metabolism ; Cell Communication ; Cell Line, Tumor ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Stromal Cells/metabolism ; Tumor Microenvironment ; Agammaglobulinaemia Tyrosine Kinase/metabolism
    Chemische Substanzen beta Catenin ; Agammaglobulinaemia Tyrosine Kinase (EC 2.7.10.2)
    Sprache Englisch
    Erscheinungsdatum 2023-12-18
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms242417623
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Identification of the Axis β-Catenin–BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment

    Imane Mihoub / Tareck Rharass / Souhaïl Ouriemmi / Antonin Oudar / Laure Aubard / Valérie Gratio / Gregory Lazarian / Jordan Ferreira / Elisabetta Dondi / Florence Cymbalista / Vincent Levy / Fanny Baran-Marszak / Nadine Varin-Blank / Dominique Ledoux / Christine Le Roy / Laura Gardano

    International Journal of Molecular Sciences, Vol 24, Iss 24, p

    2023  Band 17623

    Abstract: In the microenvironment, cell interactions are established between different cell types to regulate their migration, survival and activation. β-Catenin is a multifunctional protein that stabilizes cell–cell interactions and regulates cell survival ... ...

    Abstract In the microenvironment, cell interactions are established between different cell types to regulate their migration, survival and activation. β-Catenin is a multifunctional protein that stabilizes cell–cell interactions and regulates cell survival through its transcriptional activity. We used chronic lymphocytic leukemia (CLL) cells as a cellular model to study the role of β-catenin in regulating the adhesion of tumor cells to their microenvironment, which is necessary for tumor cell survival and accumulation. When co-cultured with a stromal cell line (HS-5), a fraction of the CLL cells adhere to stromal cells in a dynamic fashion regulated by the different levels of β-catenin expression. In non-adherent cells, β-catenin is stabilized in the cytosol and translocates into the nucleus, increasing the expression of cyclin D1. In adherent cells, the level of cytosolic β-catenin is low but membrane β-catenin helps to stabilize the adhesion of CLL to stromal cells. Indeed, the overexpression of β-catenin enhances the interaction of CLL with HS-5 cells, suggesting that this protein behaves as a regulator of cell adhesion to the stromal component and of the transcriptional regulation of cell survival. Inhibitors that block the stabilization of β-catenin alter this equilibrium and effectively disrupt the support that CLL cells receive from the cross-talk with the stroma.
    Schlagwörter β-catenin ; microenvironment ; CLL ; BTK ; stromal cells ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Thema/Rubrik (Code) 570
    Sprache Englisch
    Erscheinungsdatum 2023-12-01T00:00:00Z
    Verlag MDPI AG
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Autoimmune haemolytic anaemia associated with COVID-19 infection.

    Lazarian, Gregory / Quinquenel, Anne / Bellal, Mathieu / Siavellis, Justine / Jacquy, Caroline / Re, Daniel / Merabet, Fatiha / Mekinian, Arsene / Braun, Thorsten / Damaj, Gandhi / Delmer, Alain / Cymbalista, Florence

    British journal of haematology

    2020  Band 190, Heft 1, Seite(n) 29–31

    Mesh-Begriff(e) Aged ; Anemia, Hemolytic, Autoimmune/epidemiology ; Anemia, Hemolytic, Autoimmune/etiology ; Anemia, Hemolytic, Autoimmune/therapy ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/therapy ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; SARS-CoV-2
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-05-27
    Erscheinungsland England
    Dokumenttyp Letter
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.16794
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia.

    Lazarian, Grégory / Theves, Floriane / Hormi, Myriam / Letestu, Rémi / Eclache, Virginie / Bidet, Audrey / Cornillet-Lefebvre, Pascale / Davi, Frédéric / Delabesse, Eric / Estienne, Marie-Hélène / Etancelin, Pascaline / Kosmider, Olivier / Laibe, Sophy / Lode, Laurence / Muller, Marc / Nadal, Nathalie / Naguib, Dina / Pastoret, Cédric / Poulain, Stéphanie /
    Sujobert, Pierre / Veronese, Lauren / Imache, Samia / Lefebvre, Valérie / Cymbalista, Florence / Baran-Marszak, Fanny / Soussi, Thierry

    American journal of hematology

    2022  Band 97, Heft 4, Seite(n) E159–E162

    Mesh-Begriff(e) Chlorambucil/therapeutic use ; Codon ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Mutation ; Tumor Suppressor Protein p53/genetics
    Chemische Substanzen Codon ; TP53 protein, human ; Tumor Suppressor Protein p53 ; Chlorambucil (18D0SL7309)
    Sprache Englisch
    Erscheinungsdatum 2022-02-01
    Erscheinungsland United States
    Dokumenttyp Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 196767-8
    ISSN 1096-8652 ; 0361-8609
    ISSN (online) 1096-8652
    ISSN 0361-8609
    DOI 10.1002/ajh.26479
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Prevalence, distribution and predictive value of XPO1 mutation in a real-life chronic lymphocytic leukaemia cohort.

    Tueur, Giulia / Lazarian, Gregory / Eclache, Virginie / Fleury, Carole / Letestu, Rémi / Lévy, Vincent / Lefebvre, Valérie / Collon, Jean-Francois / Zini, Jean-Marc / Thieblemont, Catherine / Soussi, Thierry / Cymbalista, Florence / Baran-Marszak, Fanny

    British journal of haematology

    2020  Band 191, Heft 3, Seite(n) e90–e94

    Mesh-Begriff(e) Alleles ; Biomarkers, Tumor ; Clonal Evolution ; Gene Frequency ; Genetic Association Studies ; Genetic Predisposition to Disease ; Humans ; Karyopherins/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/epidemiology ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Mutation ; Prevalence ; Prognosis ; Receptors, Cytoplasmic and Nuclear/genetics ; Exportin 1 Protein
    Chemische Substanzen Biomarkers, Tumor ; Karyopherins ; Receptors, Cytoplasmic and Nuclear
    Sprache Englisch
    Erscheinungsdatum 2020-08-13
    Erscheinungsland England
    Dokumenttyp Letter
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.17046
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang